Reaction
Dyshidrotic Eczema reporting signals
As of the last recalculation, Dyshidrotic Eczema appears in 681 FAERS reports alongside 5 co-occurring drug terms. The strongest observed disproportionality signal is DOXEPIN HYDROCHLORIDE (PRR 24.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Doxepin Hydrochloride | 10 | 24.5 | 24.6 |
| Dupilumab | 199 | 17.4 | 17.4 |
| Bimekizumab | 9 | 13.1 | 13.1 |
| Ixekizumab | 12 | 10.1 | 10.1 |
| Nemolizumab-Ilto | 3 | 7.2 | 7.2 |